NYSE American - Delayed Quote USD

American Shared Hospital Services (AMS)

Compare
3.2250 -0.0050 (-0.15%)
At close: October 18 at 3:57 PM EDT
3.4900 +0.27 (+8.22%)
Pre-Market: 7:03 AM EDT
Loading Chart for AMS
DELL
  • Previous Close 3.2300
  • Open 3.1801
  • Bid 2.8600 x 800
  • Ask 3.4900 x 1000
  • Day's Range 3.1765 - 3.2400
  • 52 Week Range 2.1600 - 4.6000
  • Volume 6,459
  • Avg. Volume 127,885
  • Market Cap (intraday) 20.511M
  • Beta (5Y Monthly) 0.67
  • PE Ratio (TTM) 4.89
  • EPS (TTM) 0.6600
  • Earnings Date Nov 11, 2024 - Nov 15, 2024
  • Forward Dividend & Yield --
  • Ex-Dividend Date Jun 28, 2007
  • 1y Target Est 4.85

American Shared Hospital Services provides stereotactic radiosurgery and advanced radiation therapy equipment. It operates in two segments, Medical Equipment Leasing, and Retail. The company offers radiosurgery equipment for the Gamma Knife stereotactic radiosurgery, a non-invasive procedure to treat malignant and benign brain tumors, and arteriovenous malformations, as well as for trigeminal neuralgia. It also provides financing services for Leksell Gamma Knife units; and leases medical equipment. In addition, the company offers proton beam radiation therapy services in Orlando, Florida and Long Beach, California, as well as offers planning, installation, reimbursement, and marketing support services to its customers. The company markets its solutions to cancer treatment centers, hospitals, and cancer networks worldwide. American Shared Hospital Services was founded in 1980 and is based in San Francisco, California.

ashs.com

31

Full Time Employees

December 31

Fiscal Year Ends

Recent News: AMS

View More

Performance Overview: AMS

Trailing total returns as of 10/18/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

AMS
35.50%
S&P 500
22.95%

1-Year Return

AMS
27.98%
S&P 500
34.10%

3-Year Return

AMS
14.77%
S&P 500
31.16%

5-Year Return

AMS
32.17%
S&P 500
95.62%

Compare To: AMS

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: AMS

View More

Valuation Measures

Annual
As of 10/18/2024
  • Market Cap

    20.51M

  • Enterprise Value

    27.77M

  • Trailing P/E

    4.89

  • Forward P/E

    8.06

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.90

  • Price/Book (mrq)

    0.77

  • Enterprise Value/Revenue

    1.20

  • Enterprise Value/EBITDA

    2.48

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    18.41%

  • Return on Assets (ttm)

    2.68%

  • Return on Equity (ttm)

    14.37%

  • Revenue (ttm)

    23.1M

  • Net Income Avi to Common (ttm)

    4.25M

  • Diluted EPS (ttm)

    0.6600

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    14.24M

  • Total Debt/Equity (mrq)

    64.57%

  • Levered Free Cash Flow (ttm)

    -3.89M

Research Analysis: AMS

View More

Earnings Per Share

Consensus EPS
 

Revenue vs. Earnings

Revenue 7.06M
Earnings 3.6M
 

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell
 

Analyst Price Targets

4.85
4.85 Average
3.2250 Current
4.85 High
 

Company Insights: AMS

People Also Watch